Healthcare (Substance Abuse)

This bill restricts buprenorphine prescriptions for opioid addiction treatment to Tennessee-licensed physicians only. It creates a limited exception allowing out-of-state healthcare providers working in state or county jails to prescribe under strict conditions: requiring DEA registration, employment at correctional facilities, and adherence to approved treatment protocols. The law takes effect July 1, 2025. It directly affects prescribing practices in correctional facilities and general medical settings by clarifying who may legally prescribe these medications.

HB 1239 clarifies that only physicians licensed in Tennessee may prescribe buprenorphine for FDA-approved uses in opioid recovery or medication-assisted treatment. It also establishes new requirements for non-Tennessee-licensed healthcare providers (such as those working in correctional facilities) to prescribe buprenorphine for opioid use disorder: they must hold a federal DEA registration, be employed by or contract with a correctional facility or jail, and have clinical protocols for medication-assisted treatment. The bill revises existing law to limit prescribing authority while creating specific pathways for correctional healthcare providers. It takes effect on July 1, 2025.